An Open-Label Study Of Lamictal In Neurotic Excoriation
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the efficacy and safety of Lamictal in neurotic
excoriation. Twenty subjects with neurotic excoriation will receive 12 weeks of open-label
treatment with Lamictal. The hypothesis to be tested is that Lamictal will be effective and
well tolerated in patients with neurotic excoriation. The proposed study will provide needed
data on the treatment of a disabling disorder that currently lacks a clearly effective
treatment.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute